Skip to main content

Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

  • Chapter
  • First Online:
Gastrointestinal Malignancies

Abstract

Surgical resection improves survival for patients with gallbladder cancer and extraheptatic cholangiocarcinoma and should be considered in the absence of metastatic disease. Adjuvant chemoradiation following surgery has demonstrated benefit in multiple retrospective studies and is generally recommended for advanced T-stage, node-positive, or margin-positive disease. Definitive chemoradiation is used in patients with unresectable non-metastatic disease. This chapter outlines treatment planning approaches for adjuvant and definitive radiation as a component of multimodality therapy for patients with non-metastatic gallbladder cancer and extrahepatic cholangicarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Aloia TA, Jarufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681–90.

    Article  PubMed Central  Google Scholar 

  2. Butte JM, Gonen M, Allen PJ, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford). 2011;13(7):463–72.

    Article  Google Scholar 

  3. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11(3):310–5.

    Article  PubMed  Google Scholar 

  4. Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 study group. World J Surg. 2011;35(8):1887–97.

    Article  PubMed  Google Scholar 

  5. Hari DM, Howard JH, Leung AM, Chui CG, Sim MS, Bilchik AJ. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB (Oxford). 2013;15(1):40–8.

    Article  Google Scholar 

  6. Donohue JH, Nagorney DM, Grant CS, Tsushima K, Ilstrup DM, Adson MA. Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg. 1990;125(2):237–41.

    Article  CAS  PubMed  Google Scholar 

  7. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232(4):557–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Meng H, Wang X, Fong Y, Wang ZH, Wang Y, Zhang ZT. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992–8.

    Article  PubMed  Google Scholar 

  9. Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J Surg Oncol. 2012;10:87.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011;29(35):4627–32.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cancer survival prediction calculators. http://skynet.ohsu.edu/nomograms/gastrointestinal/gallbladder.php.

  12. Gold DG, Miller RC, Haddock MG, et al. Adjuvant therapy for gallbladder carcinoma: the mayo clinic experience. Int J Radiat Oncol Biol Phys. 2009;75(1):150–5.

    Article  CAS  PubMed  Google Scholar 

  13. Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934–40.

    Article  PubMed  Google Scholar 

  14. Kim Y, Amini N, Wilson A, et al. Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis. Ann Surg Oncol. 2016;23(9):2998–3008.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33(24):2617–22.

    Article  CAS  PubMed  Google Scholar 

  16. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.

    Article  CAS  PubMed  Google Scholar 

  17. Mahadevan A, Dagoglu N, Tseng JF, Khawaja K, Evenson A. Therapeutic potential of adjuvant stereotactic body radiotherapy for gallbladder cancer. Cureus. 2015;7(8):e299.

    PubMed  PubMed Central  Google Scholar 

  18. Elias Y, Mariano AT Jr, Lu Y. Detection of primary malignancy and metastases with FDG PET/CT in patients with cholangiocarcinomas: lesion-based comparison with contrast enhanced CT. World J Nucl Med. 2016;15(3):161–6.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):189–99.

    Article  PubMed  Google Scholar 

  20. Carpizo DR, D’Angelica M. Management and extent of resection for intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2009;18(2):289–305. viii-ix

    Article  PubMed  Google Scholar 

  21. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98(8):1689–700.

    Article  PubMed  Google Scholar 

  22. Bonet Beltran M, Allal AS, Gich I, Sole JM, Carrio I. Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies. Cancer Treat Rev. 2012;38(2):111–9.

    Article  PubMed  Google Scholar 

  23. Ghafoori AP, Nelson JW, Willett CG, et al. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2011;81(3):654–9.

    Article  PubMed  Google Scholar 

  24. Habermehl D, Lindel K, Rieken S, et al. Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation. Strahlenther Onkol. 2012;188(9):795–801.

    Article  CAS  PubMed  Google Scholar 

  25. Gerhards MF, van Gulik TM, Gonzalez Gonzalez D, Rauws EA, Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg. 2003;27(2):173–9.

    PubMed  Google Scholar 

  26. Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2009;73(1):148–53.

    Article  CAS  PubMed  Google Scholar 

  27. Tsukada K, Kurosaki I, Uchida K, et al. Lymph node spread from carcinoma of the gallbladder. Cancer. 1997;80(4):661–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kumar, R., Walker, G., Rosati, L., Ng, S.P., Herman, J. (2018). Gallbladder Cancer and Extrahepatic Cholangiocarcinoma. In: Russo, S., Hoffe, S., Kim, E. (eds) Gastrointestinal Malignancies. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-64900-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64900-9_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64899-6

  • Online ISBN: 978-3-319-64900-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics